Moderna Inc.: 10-K Risk Factor Changes

2024 vs 2023  ·  SEC EDGAR  ·  2026-10-16
Other years: 2026 vs 2025 · 2025 vs 2024
⚠ AI Risk Brief Interpretation layer — deterministic data below

Moderna added five new risk factors in 2024, led by GenAI and climate concerns, while consolidating COVID-focused disclosures.

Direction ↑ More concerning
✓ Deterministic extraction — no AI-generated data

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

5
New Risks
5
Removed
39
Modified
29
Unchanged
🟢 New in Current Filing Disclosure change10/10

Our use of GenAI and other AI technologies presents certain risks and challenges given the emerging nature of AI technologies.

🟢 New in Current Filing Climate change or legal, regulatory or market measures to address climate change may negatively affect our business, results of operations and financial condition. 🔒
🟢 New in Current Filing We may encounter difficulties producing or shipping our products consistent with our projections or future contractual commitments. 🔒
🟢 New in Current Filing Emergency authorizations that we have received for our COVID-19 vaccine for certain demographics, including pediatrics, are temporary and could be revoked. 🔒

And 45 more changes in the full comparison.

48 changes in this historical filing

The complete historical comparison (2024 vs 2023) is available on the Pro plan.

Get Pro access Already a Pro subscriber? View full diff →